In vivo and in vitro characterization of azd9343, a novel GABAB receptor agonist and reflux inhibitor

被引：0
|
作者：
Lehmann, Anders
Elebring, Thomas
Jensen, Jorgen
Mattsson, Jan P.
Nilsson, Karolina A.
Saransaari, Pigo
von Unge, Sverker
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A131 / A132
页数：2
相关论文
共 50 条
  • [21] In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator
    Porcu, Alessandra
    Lobina, Carla
    Giunta, Daniela
    Solinas, Maurizio
    Mugnaini, Claudia
    Castelli, M. Paola
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 791 : 115 - 123
  • [22] Dose-Response Effect of Lesogaberan, a Novel γ-Aminobutyric Acid Type B (GABAB) Receptor Agonist, on Reflux Episodes in Patients With Gastroesophageal Reflux Disease With Symptoms Despite Proton Pump Inhibitor Treatment
    Miner, Philip B.
    Silberg, Debra G.
    Ruth, Magnus
    Miller, Frank
    Pandolfino, John E.
    GASTROENTEROLOGY, 2011, 140 (05) : S578 - S578
  • [23] Identification and characterization of a novel adiponectin receptor agonist adipo anti-inflammation agonist and its anti-inflammatory effects in vitro and in vivo
    Qiu, Wei
    Wu, Hongle
    Hu, Zhekai
    Wu, Xingwen
    Tu, Maxwell
    Fang, Fuchun
    Zhu, Xiaofang
    Liu, Yao
    Lian, Junxiang
    Valverde, Paloma
    Van Dyke, Thomas
    Steffensen, Bjorn
    Dong, Lily Q.
    Tu, Qisheng
    Zhou, Xuedong
    Chen, Jake
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 280 - 297
  • [24] WAY-466:: In vitro and in vivo pharmacological characterization of a novel and selective 5-HT6 receptor agonist
    Schechter, LE
    Smith, DL
    Zhang, GM
    Li, P
    Lin, Q
    Lucki, I
    Rosenzweig-Lipson, S
    Robichaud, A
    Bernotas, R
    Beyer, CE
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S237 - S237
  • [25] In Vitro and In Vivo Characterization of the Novel Cathepsin C Inhibitor BI 1291583
    Kreideweiss, S.
    Schaenzle, G.
    Schnapp, G.
    Vintonyak, V.
    Grundl, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [26] A NOVEL HEDGEHOG SIGNALING INHIBITOR IN HUMAN GLIOBLASTOMA: IN VITRO AND IN VIVO CHARACTERIZATION
    Ferruzzi, Pietro
    Mennillo, Federica
    Rosa, Antonella De
    Rossi, Marco
    Giordano, Cinzia
    Magrini, Roberta
    Benedetti, Giovanni
    La Pericot, Gal
    Magnoni, Letizia
    Mori, Elisa
    Thomas, Russel
    Tunici, Patrizia
    Bakker, Annette
    NEURO-ONCOLOGY, 2010, 12 : 94 - 94
  • [27] Bifeprunox:: In vivo characterization of a novel partial agonist for the D2 receptor
    Hesselink, MB
    McCreary, AC
    Glennon, JC
    Marquis, KL
    Hertel, P
    Arnt, J
    Didriksen, M
    Long, SK
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 301 - 301
  • [28] In vitro and In vivo Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor, AZD7762
    Mitchell, James B.
    Choudhuri, Rajani
    Fabre, Kristin
    Sowers, Anastasia L.
    Citrin, Deborah
    Zabludoff, Sonya D.
    Cook, John A.
    CLINICAL CANCER RESEARCH, 2010, 16 (07) : 2076 - 2084
  • [29] In vivo effects of AZD4547, a novel fibroblast growth factor receptor inhibitor, in a mouse model of endometriosis
    Santorelli, Sara
    Fischer, Deborah P.
    Harte, Michael K.
    Laru, Johanna
    Marshall, Kay M.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (02):
  • [30] Effect of Food On the Bioavailability of AZD3355, a Novel Reflux Inhibitor, in Healthy Subjects
    Fransson, Bo
    Silberg, Debra G.
    Niazi, Mohammad
    Adler, John
    Ruth, Magnus
    GASTROENTEROLOGY, 2009, 136 (05) : A444 - A444
12345